Analysts polled by Capital IQ projected GAAP EPS of $0.98.
Total operating revenue for the quarter ended March 31 stood at $1.88 billion, up from $1.57 billion a year earlier. Five analysts surveyed by Capital IQ expected $1.61 billion.
Ameren also affirmed its 2022 EPS guidance range of $3.95 to $4.15. Analysts polled by Capital IQ expect $4.07.
Price: 94, Change: +0.75, Percent Change: +0.8
|Insider Sell: Jazz Pharmaceuticals|
|Estee Lauder Lifts Restructuring Cost Estimate to Be...|
|Sierra Oncology Shareholders Approve Acquisition by GSK|
|Insider Sell: Factset Research Systems|
|Insider Sell: Liberty Global|